5816 Federal Register / Vol. 84, No. 36 / Friday, February 22, 2019 / Rules and Regulations

ENVIRONMENTAL PROTECTION some information is not publicly B. What facilities are not subject to the AGENCY available, e.g., CBI or other information final rule? whose disclosure is restricted by statute. C. Scope of Hazardous Wastes Addressed 40 CFR Parts 261, 262, 264, 265, 266, Certain other material, such as by This Final Rule 268, 270, and 273 D. Wastes Generated at Healthcare copyrighted material, is not placed on Facilities That Are Not Included in the [EPA–HQ–RCRA–2007–0932; FRL–9988–26– the internet and will be publicly Scope of this Final Rule OLEM] available only in hard copy form. VIII. What terms are defined in this final Publicly available docket materials are rule? (§ 266.500) RIN 2050–AG39 available electronically through https:// A. Definition of Pharmaceutical www.regulations.gov. B. Definition of Hazardous Standards for Hazardous Pharmaceutical FOR FURTHER INFORMATION CONTACT: Waste Pharmaceuticals and C. Definition of Reverse Distributor Amendment to the P075 Listing for Kristin Fitzgerald, Materials Recovery D. Definition of Potentially Creditable Nicotine and Waste Management Division, Office Hazardous Waste Pharmaceutical of Resource Conservation and Recovery E. Definition of Non-Creditable Hazardous AGENCY: Environmental Protection (5304P), Environmental Protection Waste Pharmaceutical Agency (EPA). Agency, 1200 Pennsylvania Ave. NW, F. Definition of Evaluated Hazardous ACTION: Final rule. Washington, DC 20460; telephone Waste Pharmaceutical number: (703) 308–8286; email address: G. Definition of Household Waste SUMMARY: Some pharmaceuticals are [email protected], or Brian Pharmaceutical H. Definition of Non-Hazardous Waste regulated as hazardous waste under the Knieser, Materials Recovery and Waste Resource Conservation and Recovery Pharmaceutical Management Division, Office of I. Definition of Non-Pharmaceutical Act (RCRA) when discarded. This final Resource Conservation and Recovery Hazardous Waste rule adds regulations for the (5304P), Environmental Protection J. Definition of Healthcare Facility management of hazardous waste Agency, 1200 Pennsylvania Ave. NW, K. Definition of Long-Term Care Facility pharmaceuticals by healthcare facilities Washington, DC 20460; telephone IX. Applicability (§ 266.501) and reverse distributors. Healthcare number: (703) 347–8769; email address: A. What facilities are subject to the final facilities (for both humans and animals) [email protected]. Also see the rule? and reverse distributors will manage EPA’s website at https://www.epa.gov/ B. What facilities or pharmaceuticals are not subject to the final rule? their hazardous waste pharmaceuticals hwgenerators/management- under this new set of sector-specific (§§ 266.501(c) and 266.501(f) and pharmaceutical-hazardous-waste. 266.501(g)) standards in lieu of the existing SUPPLEMENTARY INFORMATION: C. Do Not Count Hazardous Waste hazardous waste generator regulations. Pharmaceuticals Managed Under Among other things, these new Table of Contents Subpart P Toward Determining regulations prohibit the disposal of The information presented in this Generator Category (§§ 262.13(c)(9)) hazardous waste pharmaceuticals down preamble is organized as follows: X. Standards for Healthcare Facilities That the drain and eliminates the dual Manage Non-Creditable Hazardous I. General Information regulation of RCRA hazardous waste Waste Pharmaceuticals (§ 266.502) A. Does this action apply to me? A. Notification/Withdrawal Requirements pharmaceuticals that are also Drug B. What action is the Agency taking? for Healthcare Facilities Managing Non- Enforcement Administration (DEA) C. What is the Agency’s statutory authority Creditable Hazardous Waste for taking this action? controlled substances. The new rules Pharmaceuticals (§ 266.502(a)) D. What are the incremental costs and also maintain the household hazardous B. Personnel